These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6279982)

  • 21. [Antibiotic sensitivity, serology and typing by pyocine in 154 cultures of Pseudomonas aeruginosa (author's transl)].
    Cantos de la Casa A; García Curiel A; Gómez Fernández MV; Arroyo Trillo A; Díaz Sánchez JA; Dueñas P
    Med Clin (Barc); 1980 Jul; 75(3):104-8. PubMed ID: 6772890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro/in vivo discrepancy of antibiotic activity against Pseudomonas aeruginosa].
    Gerber AU
    Fortschr Med; 1985 Sep; 103(34):807-10. PubMed ID: 3935553
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of antibiotics in infections due to Pseudomonas aeruginosa].
    Výmola F; Jedlicková Z
    Cesk Epidemiol Mikrobiol Imunol; 1972 Jul; 21(4):176-81. PubMed ID: 4262242
    [No Abstract]   [Full Text] [Related]  

  • 24. [Trend of therapy in Pseudomonas aeruginosa infections].
    Jannuzzi C; Tassara A
    G Mal Infett Parassit; 1971 Nov; 23(11):1051-4. PubMed ID: 5004852
    [No Abstract]   [Full Text] [Related]  

  • 25. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004.
    Messadi AA; Lamia T; Kamel B; Salima O; Monia M; Saida BR
    Burns; 2008 Dec; 34(8):1098-102. PubMed ID: 18619737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of the resistance of hospital and nonhospital strains of Pseudomonas aeruginosa to antibacterial preparations].
    Krasil'nikov AP; Adarchenko AA; Krylov IA
    Antibiotiki; 1982 Jan; 27(1):25-9. PubMed ID: 6800301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF; El-Domany RA; Zaki S; Ashour HM
    J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year report of national surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea (2002-2006).
    Yoo J; Sohn ES; Chung GT; Lee EH; Lee KR; Park YK; Lee YS
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):291-4. PubMed ID: 18068936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
    Babay HA
    Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.
    Gales AC; Jones RN; Turnidge J; Rennie R; Ramphal R
    Clin Infect Dis; 2001 May; 32 Suppl 2():S146-55. PubMed ID: 11320454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Segatore B; Perilli M; Larosa M; Setacci D; Celenza G; Amicosante G
    Int J Antimicrob Agents; 2007 Oct; 30(4):374-6. PubMed ID: 17659863
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
    Matinca D; Vancea D; Boboş C; Serban O
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
    Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibiotic, triphenylmethane dyes and boric acid in increased occurrence of Pseudomonas aeruginosa].
    Möhlenbeck F
    Z Haut Geschlechtskr; 1970 Apr; 45(8):329-32. PubMed ID: 4327229
    [No Abstract]   [Full Text] [Related]  

  • 37. Pseudomonas aeruginosa and proteus infections in premature babies and in infants. Therapeutic trial with carbenicillin.
    Korányi G; Pesti E; Somogyi G
    Acta Paediatr Acad Sci Hung; 1970; 11(2):141-50. PubMed ID: 4994152
    [No Abstract]   [Full Text] [Related]  

  • 38. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
    Walkty A; Decorby M; Nichol K; Mulvey MR; Hoban D; Zhanel G;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.